Premier Gold Offers to Purchase Centerra’s 50% Stake in Greenstone Gold Mines Partnership
Premier Gold Mines Ltd (TSX: PG), through its assignee, has offered to purchase Centerra Gold Inc (TSX: CG)‘s 50% interest
Read more
Month: March 2020
Experion Receives Amendment to Increase Processing and Cultivation Capacity
Experion Holdings Ltd (TSXV: EXP), through its wholly-owned subsidiary, Experion Biotechnologies has been granted an amendment for its Health Canada
Read more
Cronos Group Posts Revenues of US$7.3 Million For Q4 2019, Loss of US$63.8 Million
Cronos Group (TSX: CRON) (NASDAQ: CRON) has finally reported its fourth quarter and full fiscal year 2019 financial results after
Read more
CloudMD Closes Financing, Raising $3.02 Million In Aggregate
CloudMD Software & Services (CSE: DOC) this morning has closed the second and final tranche of its previously announced private
Read more
HIVE Blockchain Enters Into Agreement to Acquire Cryptologic’s Quebec Mining Operation
HIVE Blockchain Technologies Inc (TSXV: HIVE) has entered into a definitive agreement to acquire a cryptocurrency mining operation from Cryptologic
Read more
Eve & Co Accepts CFO Resignation
Eve & Co Incorporated (TSXV: EVE) has announced the resignation of the company’s Chief Financial Officer, Landon Roedding. Landon Roedding
Read more
MediPharm Labs Report sees Quarterly Revenue Drop 25%
This morning MediPharm Labs (TSX: LABS) released their fourth quarter results for the year ended December 31, 2019. The quarter
Read more
Tinley To See Final Inspections Occur At Long Beach This Week
The Tinley Beverage Company (CSE: TNY) released an update in connection with it’s much anticipated Long Beach, California facility this
Read more
Hexo Posts Net Loss of $298.2 Million, Effectively Writes Off Newstrike Transaction
Hexo Corp (TSX: HEXO) (NYSE: HEXO) released its second quarter financials this morning, in what might be referred to as
Read more
Revive Seeks To Advance Bucillamine Study To Phase 2 Clinical Study
This morning, Revive Therapeutics (CSE: RVV) released an update in relation to its ongoing study of Bucillamine for the use
Read more